Rani Therapeutics Holdings Inc (NASDAQ: RANI) kicked off on Friday, up 248.27% from the previous trading day, before settling in for the closing price of $0.47. Over the past 52 weeks, RANI has traded in a range of $0.39-$2.81.
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.78%. While this was happening, its average annual earnings per share was recorded 48.57%. With a float of $35.99 million, this company’s outstanding shares have now reached $39.24 million.
Rani Therapeutics Holdings Inc (RANI) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rani Therapeutics Holdings Inc is 24.86%, while institutional ownership is 12.06%. The most recent insider transaction that took place on Dec 13 ’24, was worth 29,993. In this transaction Chief Business Officer of this company bought 17,960 shares at a rate of $1.67, taking the stock ownership to the 17,960 shares. Before that another transaction happened on Dec 09 ’24, when Company’s Chief Executive Officer bought 10,296 for $1.94, making the entire transaction worth $19,974. This insider now owns 494,751 shares in total.
Rani Therapeutics Holdings Inc (RANI) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.24 earnings per share (EPS), higher than consensus estimate (set at -0.29) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.74% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Take a look at Rani Therapeutics Holdings Inc’s (RANI) current performance indicators. Last quarter, stock had a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 98.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Looking closely at Rani Therapeutics Holdings Inc (NASDAQ: RANI), its last 5-days average volume was 98.88 million, which is a jump from its year-to-date volume of 3.49 million. As of the previous 9 days, the stock’s Stochastic %D was 51.85%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 62.56%, which indicates a significant increase from 61.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1156 in the past 14 days, which was higher than the 0.0531 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5317, while its 200-day Moving Average is $0.9079. However, in the short run, Rani Therapeutics Holdings Inc’s stock first resistance to watch stands at $2.3100. Second resistance stands at $2.9800. The third major resistance level sits at $3.5700. If the price goes on to break the first support level at $1.0500, it is likely to go to the next support level at $0.4600.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
The company with the Market Capitalisation of 117.86 million has total of 71,869K Shares Outstanding. Its annual sales at the moment are 1,030 K in contrast with the sum of -30,020 K annual income. Company’s last quarter sales were recorded 170 K and last quarter income was -7,260 K.
